Bison Wealth’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,597
| Closed | -$355K | – | 437 |
|
|
2024
Q3 | $355K | Buy |
3,597
+857
| +31% | +$84.7K | 0.06% | 291 |
|
|
2024
Q2 | $260K | Hold |
2,740
| – | – | 0.04% | 350 |
|
|
2024
Q1 | $260K | Buy |
2,740
+216
| +9% | +$20.5K | 0.04% | 350 |
|
|
2023
Q4 | $225K | Buy |
+2,524
| New | +$225K | 0.04% | 362 |
|
|
2023
Q3 | – | Sell |
-2,466
| Closed | -$205K | – | 410 |
|
|
2023
Q2 | $205K | Buy |
+2,466
| New | +$205K | 0.04% | 355 |
|
|
2022
Q3 | – | Sell |
-31
| Closed | -$2K | – | 368 |
|
|
2022
Q2 | $2K | Hold |
31
| – | – | ﹤0.01% | 311 |
|
|
2022
Q1 | $3K | Sell |
31
-50
| -62% | -$4.84K | ﹤0.01% | 342 |
|
|
2021
Q4 | $9K | Sell |
81
-4
| -5% | -$444 | 0.01% | 303 |
|
|
2021
Q3 | $11K | Buy |
85
+4
| +5% | +$518 | 0.01% | 403 |
|
|
2021
Q2 | $11K | Hold |
81
| – | – | ﹤0.01% | 408 |
|
|
2021
Q1 | $11K | Sell |
81
-50
| -38% | -$6.79K | ﹤0.01% | 419 |
|
|
2020
Q4 | $18K | Buy |
131
+31
| +31% | +$4.26K | 0.01% | 332 |
|
|
2020
Q3 | $11K | Buy |
100
+81
| +426% | +$8.91K | 0.01% | 317 |
|
|
2020
Q2 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 345 |
|